Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) resulting in enhanced adverse effects which include drowsiness, although the scientific relevance is low in the majority of individuals – monitor the individual for adverse effects (e.If affected individual simply cannot resume the